[go: up one dir, main page]

Valori et al., 1967 - Google Patents

Urinary excretion of free noradrenaline and adrenaline following acute myocardial infarction

Valori et al., 1967

Document ID
14383185221391167860
Author
Valori C
Thomas M
Shillingford J
Publication year
Publication venue
The Lancet

External Links

Snippet

Serial measurements have been made of free noradrenaline and adrenaline in the urine of patients with acute myocardial infarction. The level of excretion of noradrenaline varied from normal values to approximately 800% of the mean normal level, and of adrenaline from …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0402—Electrocardiography, i.e. ECG
    • A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment

Similar Documents

Publication Publication Date Title
Valori et al. Urinary excretion of free noradrenaline and adrenaline following acute myocardial infarction
Johnston et al. Is maintenance digoxin necessary in patients with sinus rhythm?
Clair et al. Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
Vohra et al. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti‐depressant drugs
Gibbons et al. The safety of maximal exercise testing.
Paradis et al. Aortic pressure during human cardiac arrest: identification of pseudo-electromechanical dissociation
Singh et al. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction
Sokolow et al. Blood quinidine concentrations as a guide in the treatment of cardiac arrhythmias
Wynne et al. Oral amrinone in refractory congestive heart failure
Fletcher et al. Ventricular fibrillation in a medically supervised cardiac exercise program: clinical, angiographic, and surgical correlations
Bertorini et al. Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy
Lawson et al. Comparison of fenfluramine and metformin in treatment of obesity
Pomfret et al. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation
Russo et al. Heparin and ventricular arrhythmias after myocardial infarction
Puddu et al. QT interval measurement by a computer assisted program: a potentially useful clinical parameter
Robson et al. Use of amiodarone during pregnancy
Griffiths et al. Vincristine neurotoxicity in Charcot‐Marie‐Tooth syndrome
Holloman et al. Electrocardiogram analysis in adult patients with sickle cell disease
Powers et al. Cardiac function during weight restoration in anorexia nervosa
Gey et al. Quinidine plasma concentration and exertional arrhythmia
Holland et al. Ventricular ectopic activity with diuretic therapy
Williams et al. The frequency of asymptomatic and electrically silent exercise-induced regional myocardial ischemia during first-pass radionuclide angiography with upright bicycle ergometry
RU2112980C1 (en) Method of differentially diagnosing pulmonary complications in acute myocardial infarction and its versions
Seedat, YK, Hoosen, S. & Bhigjee Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in Black and Indian hypertensive patients
Phillips et al. Isolated T-wave abnormalities and evaluation of left ventricular wall motion after nifedipine for severe hypertension